Estatísticas para PCN239 Cost-utility of the CDK 4/6 inhibitors for postmenopausal women with HR-positive, HER2-negative advanced breast cancer in Brazil: a Dime Project

Total visits

views
PCN239 Cost-utility of the CDK 4/6 inhibitors for postmenopausal women with HR-positive, HER2-negative advanced breast cancer in Brazil: a Dime Project 0